1. IRS-2 rs1805097 polymorphism is associated with the decreased risk of colorectal cancer
   Jiefeng Yin et al, 2017, Oncotarget CrossRef
2. Single nucleotide polymorphisms in the IGF‐IRS pathway are associated with outcome in mCRC patients enrolled in the FIRE‐3 trial
   Marta Schirripa et al, 2017, International Journal of Cancer CrossRef
3. Association of IRS2 overexpression with disease progression in intrahepatic cholangiocarcinoma
   Huey‑Ling You et al, 2018, Oncology Letters CrossRef
4. The Insulin/IGF System in Colorectal Cancer Development and Resistance to Therapy
   Paolo Giovanni Vigneri et al, 2015, Frontiers in Oncology CrossRef
5. The effects of genetic variants related to insulin metabolism pathways and the interactions with lifestyles on colorectal cancer risk
   Su Yon Jung et al, 2019, Menopause CrossRef
6. Downregulation of microRNA‑126 is inversely correlated with insulin receptor substrate‑1 protein expression in colorectal cancer and is associated with advanced stages of disease
   Shicai Ye et al, 2020, Oncology Letters CrossRef